Innovations in Physics and Radiobiology Studies of Particle Therapy

Topic Information

Dear Colleagues,

The physical properties of the charged particles used in radiation therapy, such as protons, helium, oxygen, and carbon ions, have been well characterized to show that these particles have superior dose distributions compared to photon-based treatments. However, particle therapy has inherent biological advantages that have not yet been fully capitalized upon. Biologically optimized charged particle treatments could expand the therapeutic index of radiation therapy by selectively placing areas of the beam with high biological effectiveness to enhance tumor cell kill and simultaneously spare normal tissues from harm. Moreover, experimental evidence indicates that particle therapy effectiveness can be further enhanced through cutting-edge treatment modalities or combination with other cancer therapies. Notably, intriguing data suggest that particle therapy increases the immune response, meaning that, combined with immunotherapy, particle therapy may work to suppress and/or control metastatic dissemination, offering “off-target” systemic effects. This Topic welcomes fundamental studies and translational research on topics related to new technologies, physics, and radiobiology in particle therapy. Articles related to cellular and molecular responses, DNA damage repair, tumor response, normal tissue response, relative biological effectiveness modeling, radiogenomics, radioimmunotherapy, spatially fractionated radiation therapy (SFRT), boron neutron capture therapy (BNCT), and ultrahigh-dose rate FLASH particle therapy are welcome. The aim is to provide an up-to-date overview of innovations in experimental techniques, computational methods, preclinical studies, clinical outcomes, biological effect modeling, biological dose optimization, and the development of novel data analysis tools (e.g., artificial intelligence-based ones) in particle therapy.

Prof. Dr. Yidong Yang
Dr. Francesco Giuseppe Cordoni
Dr. Fada Guan
Topic Editors

Keywords

Participating Journals

Journal Name	Impact Factor	CiteScore	Launched Year	First Decision (median)	APC
Cancers cancers	4.4	8.8	2009	19.1 Days	CHF 2900	Submit
Radiation radiation	-	-	2021	23 Days	CHF 1000	Submit
Tomography tomography	2.2	3.5	2015	26.3 Days	CHF 2400	Submit
Physics physics	1.8	3.1	2019	37.8 Days	CHF 1400	Submit
Quantum Beam Science qubs	1.7	2.8	2017	31.8 Days	CHF 1600	Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (1 paper)